Peter Kosa

Molecular mechanisms associated with MS progression, severity and phenotype 7:58
Molecular mechanisms associated with MS progression, severity and phenotype
Peter Kosa • 28 Feb 2023
Future studies on damaging pathways associated with MS progression & severity 2:53
Future studies on damaging pathways associated with MS progression & severity
Peter Kosa • 28 Feb 2023
CSF biomarker-based models to predict MS outcomes 3:09
CSF biomarker-based models to predict MS outcomes
Peter Kosa • 28 Feb 2023
The content of VJNeurology is intended for healthcare professionals